Your browser doesn't support javascript.
loading
Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells.
Hur, Eun-Hye; Goo, Bon-Kwan; Moon, Juhyun; Choi, Yunsuk; Hwang, Jung Jin; Kim, Choung-Soo; Bae, Kyun Seop; Choi, Jene; Cho, Suk Young; Yang, Sang-Hwa; Seo, Jeongbeob; Lee, Gilnam; Lee, Je-Hwan.
Afiliação
  • Hur EH; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Goo BK; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Moon J; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Choi Y; Division of Hematology and Hematological Malignancies, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Hwang JJ; Institute for Innovative Cancer Research, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Kim CS; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Bae KS; Department of Clinical Pharmacology and Therapeutics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Choi J; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Cho SY; Wuxi App Tec (Shanghai) Co., Ltd. Shanghai, China.
  • Yang SH; Department of Biotechnology, College of Life Science and Biotechnology, National Creative Research Initiatives Center for Inflammatory Response Modulation, Yonsei University, Seoul, Korea.
  • Seo J; MD Healthcare, Inc., Seoul, Repulic of Korea.
  • Lee G; Department of Medicinal Chemistry, CHABIOMED Co., LTD., Seongnam-Si, Korea.
  • Lee JH; Department of Medicinal Chemistry, CHABIOMED Co., LTD., Seongnam-Si, Korea.
Oncotarget ; 8(25): 41387-41400, 2017 Jun 20.
Article em En | MEDLINE | ID: mdl-28574827

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição 4 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzimidazóis / Regulação Neoplásica da Expressão Gênica / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição 4 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article